Overview
Table of Contents
Tables and Figures
Survey Questions
Download Report Brochure
Download Sample Pages
Country or Global license Contact David Cunningham, Account Manager, 781-972-5472cunningham@healthtech.com
Length 88 pages
Date published August 2007
Additional info Single-site, country, and global licenses are multi-user, searchable, and cut-and-paste ready PDFs delivered by e-mail.
By Kevin Davies, PhD
SURVEY QUESTIONS
1. Please classify your organization. 2. What is your role in your organization? 3. What is your chief application of DNA sequencing? 4. What organisms do you chiefly sequence? 5. Do you have experience with any next-generation sequencing technology? 6. Which next-generation sequencing platform do you feel holds the most promise? 7. Which applications will benefit most from next-generation sequencing? 8. What area of disease research will benefit most from next-generation sequencing? 9. What is the biggest technical concern about next-generation sequencing platforms? 10. What do you think of the reported cost of next-generation sequencing platforms (assume a range of $300,000–$600,000)? 11. What do you predict will be the cost of full human genome sequencing by 2010? 12. Do you think one platform will emerge dominant, as ABI did in Sanger sequencing? 13. Do you foresee a role for Sanger sequencing (capillary electrophoresis) after 2010? 14. Does society need Congress to pass GINA (Genetic Information Nondiscrimination Act)?